Nicotinic receptors as SARS-CoV-2 spike co-receptors?

ACE-2, Angiotensin converting enzyme-2 BR, Binding region COVID-19 COVID-19, Coronavirus disease 2019 ETD, Extracellular topological domain Lung Nicotinic receptors PDB, Protein data bank RBD, Receptor binding domain SARS-CoV-2 SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2 hACE2 nAChRs, Nicotinic acetylcholine receptors vdw, Van der Waals

Journal

Medical hypotheses
ISSN: 1532-2777
Titre abrégé: Med Hypotheses
Pays: United States
ID NLM: 7505668

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 10 02 2021
revised: 16 11 2021
accepted: 10 12 2021
entrez: 20 12 2021
pubmed: 21 12 2021
medline: 24 12 2021
Statut: ppublish

Résumé

Nicotinic acetylcholine receptors (nAChRs) play an important role in homeostasis and respiratory diseases. Controversies regarding the association between COVID-19 hospitalizations and smoking suggest that nAChRs may contribute to SARS-CoV-2 respiratory syndrome. We recently detailed the expression and localization of all nAChR subunits in the human lung. Since virus association with nAChRs has been shown in the past, we hypothesize that nAChR subunits act as SARS-CoV-2 Spike co-receptors. Based on sequence alignment analysis, we report domains of high molecular similarities in nAChRs with the binding domain of hACE2 for SARS-CoV-2 Spike protein. This hypothesis supported by

Identifiants

pubmed: 34924680
doi: 10.1016/j.mehy.2021.110741
pii: S0306-9877(21)00260-7
pmc: PMC8669939
doi:

Substances chimiques

Receptors, Nicotinic 0
Receptors, Virus 0
Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0

Types de publication

Journal Article

Langues

eng

Pagination

110741

Informations de copyright

© 2021 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Nat Rev Neurosci. 2010 Jun;11(6):389-401
pubmed: 20485364
Science. 2020 Oct 9;370(6513):203-208
pubmed: 32817270
Nature. 2020 May;581(7807):221-224
pubmed: 32225175
Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515
pubmed: 30395287
Annu Rev Pharmacol Toxicol. 2000;40:431-58
pubmed: 10836143
Eur Respir J. 2020 Jun 4;55(6):
pubmed: 32350104
J Virol. 2018 Aug 16;92(17):
pubmed: 29925652
Am J Respir Crit Care Med. 2020 Jun 15;201(12):1557-1559
pubmed: 32329629
Eur Respir J. 2020 Jun 4;55(6):
pubmed: 32350106
Proc Natl Acad Sci U S A. 2007 May 8;104(19):8155-60
pubmed: 17470777
Int J Mol Sci. 2020 Oct 09;21(20):
pubmed: 33050277
Biochimie. 2020 Jul;174:30-33
pubmed: 32305506
Neuron. 2012 Oct 4;76(1):116-29
pubmed: 23040810
Curr Neuropharmacol. 2018;16(4):338-349
pubmed: 28901280
Toxicol Rep. 2020 Dec 19;8:73-83
pubmed: 33425684
Nat Rev Drug Discov. 2009 Sep;8(9):733-50
pubmed: 19721446
Lancet Neurol. 2020 Oct;19(10):804-805
pubmed: 32949534
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
Int J Mol Sci. 2020 Aug 13;21(16):
pubmed: 32823591
Am J Respir Crit Care Med. 2020 Jul 15;202(2):219-229
pubmed: 32432483
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
Eur Respir J. 2020 Jul 16;56(1):
pubmed: 32430431
J Gen Virol. 1996 Oct;77 ( Pt 10):2437-40
pubmed: 8887475
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Nat Neurosci. 2017 Feb;20(2):156-166
pubmed: 28092663
Acta Pharmacol Sin. 2021 Oct;42(10):1642-1652
pubmed: 33414508
Biophys J. 2021 Mar 16;120(6):983-993
pubmed: 33609494
Cell. 2020 Oct 1;183(1):16-27.e1
pubmed: 32882182
Proteins. 1987;2(4):298-307
pubmed: 3448605
Front Pharmacol. 2015 Apr 29;6:89
pubmed: 25972809
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
J Exp Med. 2021 Mar 1;218(3):
pubmed: 33433624
Molecules. 2020 Dec 28;26(1):
pubmed: 33379366
Front Immunol. 2020 Jun 11;11:1359
pubmed: 32595653
J Clin Med. 2020 May 11;9(5):
pubmed: 32403217
EMBO J. 2005 Apr 20;24(8):1634-43
pubmed: 15791205
Toxicol Rep. 2020 Apr 30;7:658-663
pubmed: 32355638
Eur Respir J. 2020 Jun 4;55(6):
pubmed: 32341101
Arterioscler Thromb Vasc Biol. 2011 Apr;31(4):928-34
pubmed: 21051662
Ann N Y Acad Sci. 2001 Jun;940:110-8
pubmed: 11458670
Atherosclerosis. 2012 Dec;225(2):264-73
pubmed: 22929083
Science. 1982 Jan 8;215(4529):182-4
pubmed: 7053569
Curr Opin Neurobiol. 2014 Dec;29:88-95
pubmed: 24983212
Pept Res. 1989 May-Jun;2(3):221-6
pubmed: 2520759
Lancet Haematol. 2020 Jun;7(6):e438-e440
pubmed: 32407672
Eur Respir J. 2020 Jul 16;56(1):
pubmed: 32398309
Ann Otol Rhinol Laryngol. 2003 Jan;112(1):77-84
pubmed: 12537063
Nature. 2020 May;581(7807):215-220
pubmed: 32225176
Med Sci Monit. 2020 May 28;26:e926016
pubmed: 32463026
J Mol Recognit. 1990 Apr;3(2):82-8
pubmed: 2361061
Cell. 2020 May 14;181(4):894-904.e9
pubmed: 32275855
Nature. 2000 May 25;405(6785):458-62
pubmed: 10839541

Auteurs

Valérian Dormoy (V)

University of Reims Champagne-Ardenne, Inserm, P3Cell UMR-S1250, SFR CAP-SANTE, 51092 Reims, France.

Jeanne-Marie Perotin (JM)

University of Reims Champagne-Ardenne, Inserm, P3Cell UMR-S1250, SFR CAP-SANTE, 51092 Reims, France.
CHU of Reims, Hôpital Maison Blanche, Department of Respiratory Diseases, 51092 Reims, France.

Philippe Gosset (P)

University of Lille, CNRS UMR8204, Inserm U1019, CHRU Lille, Institut Pasteur Lille, CIIL - Center for Infection and Immunity of Lille, 59000 Lille, France.

Uwe Maskos (U)

Institut Pasteur Paris, Université de Paris, Integrative Neurobiology of Cholinergic Systems, CNRS, UMR 3571, Paris, France.

Myriam Polette (M)

University of Reims Champagne-Ardenne, Inserm, P3Cell UMR-S1250, SFR CAP-SANTE, 51092 Reims, France.
CHU Reims, Hôpital Maison Blanche, Department of Biopathology, 51092 Reims, France.

Gaëtan Deslée (G)

University of Reims Champagne-Ardenne, Inserm, P3Cell UMR-S1250, SFR CAP-SANTE, 51092 Reims, France.
CHU of Reims, Hôpital Maison Blanche, Department of Respiratory Diseases, 51092 Reims, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH